sábado, 20 de febrero de 2010

Access to essential medicines: A very good news!

An Indian court has stopped the international pharmaceutical company Bayer’s latest attempt to introduce new measures to prevent generic competition in India. By ruling against Bayer on 9 February 2010, the Delhi High Court has refused to undermine measures in India’s patent laws that help ensure access to more affordable essential medicines for patients in need.

No hay comentarios: